Becton, Dickinson Boosts FY26 Adj. EPS Outlook - Update
Becton, Dickinson and Co. (BDX) reported third-quarter results and raised its FY2026 adjusted EPS outlook to $12.62 to $12.72 per share, from $12.52 to $12.72. The company kept its revenue growth view, expecting low single-digit plus growth and low single-digit constant-currency growth. Shares were about $172.00 premarket.
How this was made
The 30-second read
Why it matters
The key tradable input is the revised FY26 adjusted EPS range, which can shift expectations for FY26 earnings power and near-term positioning ahead of subsequent quarters.
Market read
A guidance update with explicit EPS numbers can drive earnings-multiple repricing and short-term momentum, especially if traders were positioned for flat or lower guidance.
What to watch
Revenue growth outlook is maintained (low single-digit plus), so traders may focus on whether the EPS lift is driven by cost actions that could be temporary.
Background
BDX reported Q3 results and updated its full-year 2026 adjusted EPS guidance while keeping its revenue growth outlook unchanged.
Ticker impact
Becton, Dickinson raised its FY26 adjusted EPS outlook to $12.62 to $12.72, up from $12.52 to $12.72.
Likely supportive for the stock on guidance optimism, with follow-through depending on whether revenue growth assumptions hold.
The article discloses a specific upward revision to the lower end of FY26 adjusted EPS while keeping revenue growth outlook unchanged, which typically reduces downside risk more than it boosts upside.
Market effects
Signals continued stability in medical device earnings expectations, potentially modestly supportive for large-cap medtech sentiment.
Primarily US large-cap medtech sentiment; limited direct regional spillover implied.
No explicit global demand or regulatory changes cited beyond constant-currency revenue growth framing.
Counterpoint
The guidance raise is only to the lower bound, so upside may be limited if margins or demand do not improve further.
Key entities
- companyBecton, Dickinson and Co.
Raised FY26 adjusted EPS guidance range to $12.62 to $12.72 per share, up from $12.52 to $12.72.
